A61P 1 - Drugs for disorders of the alimentary tract or the digestive system

Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
08/2002
08/14/2002	CN1363324A Nano medicine 'Zhishu' and its preparing process
08/14/2002	CN1363323A Nano method 'Zhishi Daozhi' and its preparing process
08/14/2002	CN1363321A Nano medicine for treating hepatitis B, antipyresis and detoxication and its preparing process
08/14/2002	CN1363317A Medicine for treating biliary calculus and its preparing process
08/14/2002	CN1363315A Medicine for treating renal calculus and its preparing process
08/14/2002	CN1363313A Nano medicine 'Liangfu' and its preparing process
08/14/2002	CN1363312A Nano medicine for regulating function of kidney and spleen and its preparing process
08/14/2002	CN1363311A Nano medicine 'Kaixiong Shunqi' and its preparing process
08/14/2002	CN1363309A Nano medicine 'jintan' and its preparing process
08/14/2002	CN1363307A Nano medicine 'Guiluningshen' and its preparing process
08/14/2002	CN1363305A Nano compound fleece flower root-rehmannia root medicine and its preparing process
08/14/2002	CN1363304A Nano medicine for strengthening patient's resistance and nourishing essence and its preparing process
08/14/2002	CN1363301A Nano medicine 'Ermiao' and its preparing process
08/14/2002	CN1363298A Nano medicine for nourishing kidney and blood and its preparing process
08/14/2002	CN1363295A Nano medicine 'Yougui' and its preparing process
08/14/2002	CN1363292A Nano medicine for helping digestion of baby and its preparing process
08/14/2002	CN1363291A Nano medicine for treating baby diarrhea and its preparing process
08/14/2002	CN1363290A Nano medicine 'Shenshu' for invigorating function of baby spleen and its preparing process
08/14/2002	CN1363289A Nano medicine for relieving inflammation and normalizing secretion of bile and its preparing process
08/14/2002	CN1363285A Nano ginseng medicine for invigorating function of spleen and its preparing process
08/14/2002	CN1363281A Application of carboxymethyl chitosan in treating gastritis and gastric ulcer
08/14/2002	CN1363280A Composition for preventing and treating enterotoxic syndrome of meat chicken
08/14/2002	CN1089002C Chinese patent medicine for treating oral ulcer and Baiser's disease
08/14/2002	CN1089000C Power-medicine for chicken
08/13/2002	US6433202 Antiinflammatory agents
08/13/2002	US6433175 Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists
08/13/2002	US6433165 Chemokine receptor antagonists and methods of use therefor
08/13/2002	US6433026 Process for removing bile salts from a patient and alkylated compositions therefor
08/13/2002	US6433009 Treatment of autoimmune, cardiovascular, nervous system, gastrointestinal, respiratory system, and viral disorders; antidiabetic, antiarthritic, antiinflammatory and antidepressant agents
08/13/2002	US6433008 Treating parkinsons, alzheimers, autoimmune and rheumatic diseases; human immunodeficiency virus (hiv) dementia, and inflammation
08/13/2002	US6433001 1H-indole-3-glyoxylamide sPLA2 inhibitors
08/13/2002	US6432994 Cardiovascular disorders, glaucoma; antiinflammatory, wound healing, hypotensive, antiasthmatic, and antianaphylactic agents
08/13/2002	US6432989 Use of CRF antagonists to treat circadian rhythm disorders
08/13/2002	US6432988 2-arylalkylthio -imidazoles, 2-arylalkenyl -thio -imidazoles and 2-arylalkinyl -thio -imidazoles as anti -inflammatory substances and substances inhibiting the release of cytokine
08/13/2002	US6432966 Antiviral combinations
08/13/2002	US6432962 Antiinflammatory agents
08/13/2002	US6432952 Central nervous system disorders; antiinflammatory agents
08/13/2002	US6432949 Amide derivatives useful as inhibitors of the production of cytokines
08/13/2002	US6432948 Use of 7-(2-oxa-5,8-diazabicylco[4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for the treatment of heliobacter pylori infections and associated gastroduodenal diseases
08/13/2002	US6432947 N-heterocyclic derivatives as NOS inhibitors
08/13/2002	US6432659 Motor proteins and methods for their use
08/13/2002	US6432449 Anionic polysaccharides coupled with a metal and a complex leptin protein; biocompatible injections having no side effects
08/13/2002	US6432415 Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfaces
08/13/2002	CA2127987C Pharmaceutical bacteriocin compositions
08/13/2002	CA2045594C Immunogenic compositions against gastrin peptides
08/12/2002	CA2369967A1 Methods of treating nuclear factor-kappa b mediated diseases and disorders
08/08/2002	WO2002061110A2 Nucleic acid derivatives
08/08/2002	WO2002061105A2 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc)
08/08/2002	WO2002061086A2 Human leucine-rich repeat containing protein expressed predominately in small intestine, hlrrsi1
08/08/2002	WO2002061052A2 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods
08/08/2002	WO2002060942A2 Protein modification and maintenance molecules
08/08/2002	WO2002060932A2 A serpin in bifidobacteria
08/08/2002	WO2002060931A2 A fimbria-like gene in bifidobacteria
08/08/2002	WO2002060926A2 Hepatitis c tripeptide inhibitors
08/08/2002	WO2002060903A1 Substituted indolines as 5-ht receptor ligands
08/08/2002	WO2002060900A2 Antagonists of mcp-1 function and methods of use thereof
08/08/2002	WO2002060898A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes
08/08/2002	WO2002060897A2 Process for making substituted 8-arylquinolinium benzenesulfonate
08/08/2002	WO2002060896A1 Ether derivatives useful as inhibitors of pde4 isozymes
08/08/2002	WO2002060895A1 Diazocine derivatives and their use as tryptase inhibitors
08/08/2002	WO2002060894A2 Sulfonamide lactam inhibitors of factor xa
08/08/2002	WO2002060875A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
08/08/2002	WO2002060859A2 Cyclic derivatives as modulators of chemokine receptor activity
08/08/2002	WO2002060474A2 Mixtures of mushroom enzymes and the use thereof for treating maldigestion
08/08/2002	WO2002060472A1 Remedies for hyponutrition status
08/08/2002	WO2002060463A1 Lower alcohol-insoluble extract of hovenia dulcis var. koreana nakai, a polysaccharide isolated therefrom and an antihepatotoxic composition containing same
08/08/2002	WO2002060458A2 Compositions and method of tissue superoxygenation
08/08/2002	WO2002060457A1 Anti-stress agents
08/08/2002	WO2002060449A2 Pharmaceutical formulation containing pyrazolo[4,3-d]pyrimidine and nitrates or thienopyrimidines and nitrates
08/08/2002	WO2002060447A1 Receptor selective cannabimimetic aminoalkylindoles
08/08/2002	WO2002060445A1 Kappa opioid receptor ligands
08/08/2002	WO2002060442A1 Novel forms of 2,3-dimethyl-8-(2-ethyl-6-methylbenzylamino)-imidazo (1,2-a)pyridine-6-carboxamide
08/08/2002	WO2002060441A1 Novel forms of 2,3-dimethyl-8-(2-ethyl-6-methylbenzylamino)-imidazo (1,2-a)pyridine-6-carboxamide
08/08/2002	WO2002060440A1 Novel forms of 2,3-dimethyl-8-(2-ethyl-6-methylbenzylamino)-imidazo (1,2-a)pyridine-6-carboxamide
08/08/2002	WO2002060435A1 Cryptotanshinone for preventing and alleviating alzheimer's disease
08/08/2002	WO2002060434A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
08/08/2002	WO2002060423A2 Substituted carbostyril derivatives as 5-ht1a receptor subtype agonists
08/08/2002	WO2002060415A1 Multi-particulate form of medicament, comprising at least two differently coated forms of pellet
08/08/2002	WO2002060388A2 Acyl sulfamides for treatment of obesity, diabetes and lipid disorders
08/08/2002	WO2002060386A2 METHODS OF TREATING INFLAMMATORY AND IMMUNE DISEASES USING INHIBITORS OF IλB KINASE (IKK)
08/08/2002	WO2002060378A2 Substituted aryl compounds as cyclooxygenase-2 selective inhibitors, compositions and methods of use
08/08/2002	WO2002060279A1 $g(a)-lactalbumin as prebiotic agent
08/08/2002	WO2002060276A1 Combination of probiotics
08/08/2002	WO2002044142A3 Piperazine derivatives, their preparation and their use for treating central nervous system (cns) disorders
08/08/2002	WO2002034716A3 Pyrrolidine modulators of ccr5 chemokine receptor activity
08/08/2002	WO2002032900A3 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
08/08/2002	WO2002030455A3 Agents for the treatment of viral infections
08/08/2002	WO2002028165A3 Compositions and methods of using capsid protein from flaviviruses and pestiviruses
08/08/2002	WO2002020762A3 Tnf receptor-like molecules and uses thereof
08/08/2002	WO2002015722A3 Treatment of helicobacter with isothiocyanates
08/08/2002	WO2002010140A3 Imidazolyl derivatives
08/08/2002	WO2002009690A3 Pharmaceutical composition comprising a photochemotherapeutic agent and a mucoadhesive agent
08/08/2002	WO2002006189A3 Aniline derivatives
08/08/2002	WO2002005801A3 Compositions containing diacyltartaric salts of (e)-metanicotine
08/08/2002	WO2002002744A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
08/08/2002	WO2002000631A3 Benzhydryl derivatives
08/08/2002	WO2001098268A3 Piperidine amides as modulators of chemokine receptor activity
08/08/2002	WO2001096546A3 Protein phosphatases
08/08/2002	WO2001081585A3 A thymus expressed human cytochrome p450 (p450tec)
08/08/2002	WO2001081334A3 Cyclic amidine compounds and their use as alpha4beta2 nicotinic acetylcholine receptor ligands

1 ... 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 ... 1258